Clinical Trials · NCT04878406
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 24
- Start date
- May 2021
- Locations
- 1 site, Japan
- Primary endpoint
- Number of treatment emergent adverse events (TEAEs)